Growth Metrics

Pfizer (PFE) Goodwill (2016 - 2026)

Pfizer has reported Goodwill over the past 18 years, most recently at $71.4 billion for Q1 2026.

  • Quarterly Goodwill rose 4.33% to $71.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $71.4 billion through Mar 2026, up 4.33% year-over-year, with the annual reading at $71.3 billion for FY2025, 3.99% up from the prior year.
  • Goodwill was $71.4 billion for Q1 2026 at Pfizer, roughly flat from $71.3 billion in the prior quarter.
  • Over five years, Goodwill peaked at $71.4 billion in Q1 2026 and troughed at $49.4 billion in Q4 2022.
  • The 5-year median for Goodwill is $68.4 billion (2025), against an average of $61.6 billion.
  • Year-over-year, Goodwill skyrocketed 34.62% in 2024 and then dropped 1.23% in 2025.
  • A 5-year view of Goodwill shows it stood at $51.4 billion in 2022, then surged by 31.94% to $67.8 billion in 2023, then rose by 1.1% to $68.5 billion in 2024, then increased by 3.99% to $71.3 billion in 2025, then increased by 0.2% to $71.4 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Goodwill are $71.4 billion (Q1 2026), $71.3 billion (Q4 2025), and $69.1 billion (Q3 2025).